General Information
BounceWatch is an independent company data service, not affiliated with Metamodix. To contact Metamodix, visit metamodix.com.
Is this your company?
Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.
Get Verified
Discover More
About Metamodix
Taxonomy: Type 2 Diabetes, Metabolic Diseases, EndoSleeve, Non-surgical therapy, Weight Reduction, NASH treatment, Obesity, Healthcare Innovation, Medical Instruments, Health Technology, Innovative Treatment, Healthcare Solutions, Diabetes Management, Medical Technology
Funding Rounds & Investors (11)
View All| Funding Stage | Amount | Investors | Lead Investors | Date |
|---|---|---|---|---|
| Venture Round | $500.00K | - |
|
26 Jan 2023 |
| Venture Round | $100.00K | - |
|
12 Jul 2018 |
| Venture Round | $1.20M | - |
|
29 Mar 2017 |
| Venture Round | $100.00K | - |
|
23 Dec 2016 |
| Venture Round | $141.99K | - |
|
08 May 2016 |
| Series A | $1.75M | 1 |
Antipodean Advisors
|
24 Jun 2015 |
| Venture Round | $29.43K | - |
|
13 Jan 2015 |
| Venture Round | $150.00K | - |
|
08 Apr 2014 |
| Venture Round | $450.00K | - |
|
28 Mar 2013 |
| Seed Round | $993.75K | - |
|
05 Jun 2012 |
Metamodix Alternatives & Competitors
View All AlternativesInnovative therapies for type 2 diabetes and obesity, rooted in excellence since 2003.
Dedicated to novel therapies that can sustain long term weight management.
America’s premier weight-loss and metabolic health-solutions company.
FAQ About Metamodix
Source: BounceWatch company record for Metamodix, https://bouncewatch.com/company/metamodix, updated 9 November 2024. When citing, please name BounceWatch and link this page.